Dr. Douglas G. Shemin, MD

Dr. Shemin practices at The Miriam Hospital in Providence, Rhode Island, part of Brown University Health.

Dr. Shemin's NPI, 1710934724, was assigned on May 27, 2006. Dr. Shemin attended State University of New York at Buffalo School of Medicine. Dr. Shemin holds Rhode Island license MD06411.

Dr. Shemin's primary practice is The Miriam Hospital, at 164 Summit Avenue, Providence, RI 02906 in Providence County. The practice phone is (401) 793-2500.

Dr. Shemin's primary practice is The Miriam Hospital in Providence, Rhode Island, part of Brown University Health. The medical group on file is Brown Medicine. Dmand AI also links Dr. Shemin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shemin practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Shemin's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Shemin is licensed in Rhode Island.

CMS data shows 151 Medicare services from Dr. Shemin across 4 procedure codes in 2024, for 107 Medicare patients. Medicare paid $17,839 for them.

CMS counts 107 Medicare patients who saw Dr. Shemin in 2024. The largest group is 75 to 84, with 37 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 3.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shemin's median patient age at 75, with 53% women.

In 2024, Dr. Shemin wrote 878 Medicare Part D claims for 138 patients. 84% of them were for generic drugs. CMS names the drug for 638 of them, across 22 drugs with 11 or more claims each, at $61,499 in total drug cost. In 2023, CMS named 1,276 claims across 36 drugs.

Dr. Shemin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Shemin, published from 2016 to 2023. 2020 was the busiest year, with 4. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Acute Kidney Injury. Dr. Shemin has published most often in Am J Kidney Dis. Dr. Shemin's most frequent co-authors are George P. Bayliss, MD, Lance D. Dworkin, MD and Yousef Elfanagely, MD.

Dmand AI links Dr. Shemin to 2 clinical trials. Conditions studied include Kidney Failure, Chronic, Renal Insufficiency, Chronic and Atrial Fibrillation. Open Payments lists research payments to Dr. Shemin that name 1 trial.

CMS Open Payments shows 62 general payments to Dr. Shemin from 10 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 54% of the total. AstraZeneca Pharmaceuticals LP paid the most, $21,604. It also lists 17 research payments totaling $2,760 from 2016 to 2019, naming 1 clinical trial.

Dr. Shemin attended State University of New York at Buffalo School of Medicine.